Carregant...
Tocilizumab: A Review in Rheumatoid Arthritis
Intravenous (IV) and subcutaneous (SC) tocilizumab (RoActemra(®)), an IL-6 receptor antagonist, are approved (± methotrexate) in numerous countries throughout the world, for the treatment of adults with moderate to severe active rheumatoid arthritis (RA). Extensive clinical experience has firmly est...
Guardat en:
| Publicat a: | Drugs |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer International Publishing
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5736769/ https://ncbi.nlm.nih.gov/pubmed/29094311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-017-0829-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|